4
Changes in Ownership
ACADIA PHARMACEUTICALS INC Filed Acc 0001209191-23-042641
CEO sold 100,000 shares at $30.04 ($3,004,350)
- CEO acquired 100,000 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| DAVIS STEPHEN CEO | 2023-07-14 | Option exercise 10b5-1 | +100,000 | $20.77 | $2,077,000 | 136,695 | D |
| DAVIS STEPHEN CEO | 2023-07-14 | Sale 10b5-1 | −100,000 | $30.04 | $3,004,350 | 36,695 | D |
| Derivatives | |||||||
| DAVIS STEPHEN CEO | 2023-07-14 | Option exercise · Stock Option (Right to Buy) 10b5-1 | −100,000 | 220,000 | D | ||
| Open-market sales · 100,000 sh · avg $30.04 · $3,004,350 | |||||||
Loading xslF345X05/doc4.xml…